The King’s Policy Institute, the Office of Health Economics and RAND Europe developed a methodology to estimate how many pounds of pharmaceutical industry R&D is stimulated in the UK by public or charity spending on medical research.
To support the coordination of mental health research, RAND Europe mapped the research funding ‘ecosystem’. Researchers explored who the major funders are, what kinds of research they support, and how their strategies relate to one another.
A series of interviews and workshops helped RAND Europe evaluate three measures proposed as part of the NHS Accelerated Access Review interim report to encourage the adoption of innovation. RAND assessed the feasibility of the measures and factors likely to facilitate or challenge their success.
A series of social innovation pilot projects across Europe aim to support the growth of European social finance markets and the development of capacities within social business and young entrepreneurship. RAND Europe and Ecorys evaluated the pilots and hosted a series of interactive workshops to encourage an exchange of experiences.
The digital dependence in developed countries has led to a situation where security vulnerabilities and security incidents potentially come accompanied by serious consequences. With this in mind, RAND Europe investigated why, where and how organisations in critical infrastructure sectors invest in cybersecurity.
The Department of Health’s strategy for improving care and creating greater wealth through innovation, known as ‘Innovation, Health and Wealth’ (IHW), has the potential to systematically change the way the NHS operates. RAND Europe evaluated whether and how IHW actions have worked as planned and contributed to achieving the strategy's overarching aims.
Research for the Higher Education Funding Council of England shows that five key themes are associated with high performance in UK higher education institutions: people; culture, values and leadership; strategy and funding; collaboration and networks; and institutional and departmental practice.
The Digital Catapult targets market and innovation inefficiencies that likely inhibit the up-take of data-driven innovation across sectors. RAND Europe research frames thinking about how the Digital Catapult can contribute to economic productivity.
The potential economic benefits of projects funded through the National Institute for Health Research’s Health Technology Assessment programme would go well beyond covering the programme’s costs, according to an assessment done by RAND Europe and based on a sample of 10 projects.
To help frame the debate on future EU membership in the context of UK health research, RAND Europe assessed the benefits and burdens of membership. This research, for the Department of Health, not only focuses on funding, but also looks at other aspects such as research environment, network effects, and knowledge spillovers. The project included a series of scenario-based workshops to explore future impact of EU funding.
Researchers designed a system through which The Research Council of Oman can measure the performance and impact of its funded research today and in the future. The team also collected data to set a baseline for a subset of the performance and impact indicators developed for the system.
Aiming to better understand the contexts that have contributed to breakthroughs in treatment, this project analysed breakthroughs in four conditions of ill health and sought to identify potentially transferable lessons for the dementia context.
The International AIDS Vaccine Initiative (IAVI) helps to bridge the gap between scientific and technological potential and the needs of low income populations in low and middle income countries. RAND Europe evaluated its capacity-building activities — including training, advocacy and broader community engagement activities — in Uganda, Kenya and Rwanda.
The National Institute of Health Research Leadership Programme was established in 2009 to develop the leadership skills and capabilities of current and future NIHR researchers. RAND Europe undertook a 2-year real-time evaluation of the second phase of the programme in 2012-2014.
RAND Europe supported the Accelerated Access Review of innovative medicines and medical technologies by examining international examples of accelerating the use of drugs, devices and diagnostics. One key conclusion is that a systems approach to speeding up the adoption of medical innovation will be necessary.
To inform and support Cambridge Neuroscience in their strategic direction, RAND Europe conducted a biblometric analysis that provides evidence on the research performance of the network (and its constituent researchers and organisational units) and explores collaboration dynamics.
At a Cambridge University conference on Policy Making in the Big Data Era, Joanna Chataway presented findings from a RAND Europe study assessing the real-world data policy landscape for health and healthcare in Europe.
The i4i programme supports the development of innovative medical technologies and their translation into clinical practice. RAND Europe evaluated i4i to identify its impacts and the factors influencing performance.
To formulate evidence-based conclusions and recommendations for improving the processes of preparing submissions for impact assessment, the higher education funding councils for England, Scotland and Wales asked RAND Europe to work with a sample of higher education institutions to evaluate the submission process for the impact element of the Research Excellence Framework (REF) 2014.
Following RAND Europe's evaluation of the Research Excellence Framework submission process, the four UK higher education funding bodies commissioned an evaluation of the assessment process for the impact element of the REF 2014.
Around 80,000 premises in the UK are located in areas without mobile phone coverage – referred to as “not-spots”. Residents and businesses in these areas would be willing to pay for a mobile phone signal, according to RAND Europe research. Further, these areas may not be sustainable in the longer term without a signal, due to the negative impacts on business profits.
Innovation is a complex system with many interacting factors, which means that 'magic bullet' solutions do not exist to enhance the innovation process. RAND Europe identified eight key factors that can be used to understand innovation systems and to focus effort on being able to harness innovation for the defence industry.
‘Science 2.0’ describes the on-going evolution in the modus operandi of doing research and organising science in Europe. RAND Europe reviewed the public consultation on this EU project and developed an interactive website on which participants and interested individuals could comment on the validation process of the public consultation.
As digital technology becomes more relevant in diverse aspects of our economy and society, it is important to anticipate changes in technology and how we use it. This understanding is particularly important for Horizon 2020, the EU’s 7-year research and innovation funding programme.